WHO issues new guidelines for gene editing; Doudna-backed Caribou launches its first allogeneic CAR-T trial July 12, 2021
Innovent Announces NMPA Acceptance of New Drug Application for the FGFR1/2/3 Inhibitor (Pemigatinib) for the Treatment of Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement July 8, 2021
Innovent and Laekna Therapeutics Enter a Partnership Agreement to Co-Develop Combination Therapy of Sintilimab and Afuresertib in Clinical Studies in China July 5, 2021
Rallybio Announces Clinical Proof of Concept for RLYB211, an Anti-HPA-1a Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) July 2, 2021
Significant Continued Progress with Formulary Uptake of BARHEMSYS® and BYFAVO™ in the US July 1, 2021
Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo autologous HSC Gene Therapy for Hereditary Angioedema July 1, 2021
Apellis and Beam Therapeutics Enter Exclusive Research Collaboration to Apply Base Editing to Discover Novel Therapies for Complement-Driven Diseases June 30, 2021
Carrot Fertility and RESOLVE Uncover Fertility and Family-Forming Trends in New Fertility at Work Study June 30, 2021